Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 10,526–10,550 of 27,380 studies, newest first · page 422 of 1096.

February 2021 25

  1. 2021-02-17

    Caregiver identity in care partners of persons living with mild cognitive impairment

    ✓ Peer-reviewed Caregiving Dementia (London, England)

    Key finding: These themes influenced how participants primarily identified, represented as I am a caregiver, I am not a caregiver, or liminality (i.e., between their previous identity and a caregiver identity). +4 more findings

  2. 2021-02-17

    Small Area Estimation under Spatial Multivariate Fay--Herriot Model

    ✓ Peer-reviewed Risk factors Not indexed

    Key finding: The empirical results clearly show that the proposed small area predictor outperforms the existing predictors.

  3. 2021-02-17

    Small Area Estimation under Spatial Multivariate Fay–Herriot Model

    ✓ Peer-reviewed Risk factors Not indexed

    Key finding: The empirical results clearly show that the proposed small area predictor outperforms the existing predictors.

  4. 2021-02-17

    Neighborhood Sidewalk Environment and Incidence of Dementia in Older Japanese Adults

    ✓ Peer-reviewed Risk factors American Journal of Epidemiology

    Key finding: In urban areas, compared with the lowest quartile of sidewalk coverage, the hazard ratio was 0.42 (95% confidence interval: 0.33, 0.54) for the highest quartile, adjusting for individual covariates. +2 more findings

  5. 2021-02-17

    Iron loading is a prominent feature of activated microglia in Alzheimer's disease patients

    ✓ Peer-reviewed Inflammation and the immune system Acta neuropathologica communications

    Key finding: Microglia have been identified as key players in the disease pathogenesis, and are highly reactive cells responding to aberrations such as increased iron levels. +3 more findings

  6. 2021-02-17

    Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker

    ✓ Peer-reviewed TREM2 and immune genetics Frontiers in immunology

    Key finding: Although increasing evidence supports a vital role for TREM2 in tumorigenesis of some cancers, no systematic pan-cancer analysis of TREM2 is available. +3 more findings

  7. 2021-02-17

    Rheumatoid arthritis: Extra-articular manifestations and comorbidities

    ✓ Peer-reviewed How common it is Autoimmunity reviews

    Key finding: Compared to the general population, patients with RA have twice the risk of myocardial infarction and up to 50% increased CV mortality risk. +2 more findings

  8. 2021-02-16

    Associations among Cognitive Functions, Plasma DNA, and Diffusion Tensor Image along the Perivascular Space (DTI-ALPS) in Patients with Parkinson's Disease

    ✓ Peer-reviewed Inflammation and the immune system Oxidative medicine and cellular longevity

    Key finding: Parkinson's disease (PD) is a common neurodegenerative disease associated with accumulation of misfolding proteins and increased neuroinflammation, which may further impair the glymphatic system. +3 more findings

  9. 2021-02-16

    Cognitive Profile and Markers of Alzheimer Disease-Type Pathology in Patients With Lewy Body Dementias

    ✓ Peer-reviewed Tau biomarkers Neurology

    Key finding: We selected 57 patients with LBD (dementia with Lewy bodies [DLB], n = 38; Parkinson disease dementia [PDD], n = 19) with available AD CSF biomarkers and neuropsychological data. +3 more findings

  10. 2021-02-16

    Machine Learning Algorithms and Statistical Approaches for Alzheimer's Disease Analysis Based on Resting-State EEG Recordings: A Systematic Review

    ✓ Peer-reviewed Digital health tools International journal of neural systems

    Key finding: Alzheimer's Disease (AD) is a neurodegenerative disorder and the most common type of dementia with a great prevalence in western countries.

  11. 2021-02-15

    Machine learning identifies candidates for drug repurposing in Alzheimer's disease

    ✓ Peer-reviewed Drug development Nature communications

    Key finding: Clinical trials of novel therapeutics for Alzheimer's Disease (AD) have consumed a large amount of time and resources with largely negative results.

  12. 2021-02-15

    Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer's disease risk genes

    ✓ Peer-reviewed Genetics Nature genetics

    Key finding: Genome-wide association studies have discovered numerous genomic loci associated with Alzheimer's disease (AD); yet the causal genes and variants are incompletely identified. +1 more finding

  13. 2021-02-15
  14. 2021-02-15

    Plasma d-glutamate levels for detecting mild cognitive impairment and Alzheimer's disease: Machine learning approaches

    ✓ Peer-reviewed Digital health tools Journal of psychopharmacology (Oxford, England)

    Key finding: This study aimed to use peripheral plasma d-glutamate levels to differentiate patients with mild cognitive impairment (MCI) and Alzheimer's disease (AD) from healthy individuals and to evaluate its prediction ability using machine learning. +3 more findings

  15. 2021-02-15

    Association of Digital Clock Drawing With PET Amyloid and Tau Pathology in Normal Older Adults

    ✓ Peer-reviewed Brain scans and imaging Neurology

    Key finding: DCTclock discriminates between diagnostic groups and improves upon traditional cognitive tests for detecting biomarkers of amyloid and tau pathology in CN older adults. +2 more findings

  16. 2021-02-15

    Home-based multimodal exercise program in older people with Alzheimer disease: Randomized controlled trial protocol

    ✓ Peer-reviewed Treatments Physiotherapy research international : the journal for researchers and clinicians in physical therapy

    Key finding: Improvements in the aspects evaluated are expected in the IG compared to CG.

  17. 2021-02-14

    Association between exenatide use and incidence of Alzheimer's disease

    ✓ Peer-reviewed Drug development Alzheimer's & dementia (New York, N. Y.)

    Key finding: The sample was mostly female (65%), White (76%), and 74 years old on average. +4 more findings

  18. 2021-02-14

    HbA1c and brain health across the entire glycaemic spectrum

    ✓ Peer-reviewed Long-term cohort studies Diabetes, obesity & metabolism

    Key finding: HbA1c and diabetes diagnosis were used to define baseline glycaemic categories. +3 more findings

  19. 2021-02-14

    Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology

    ✓ Peer-reviewed Getting a diagnosis Acta neuropathologica

    Key finding: Furthermore, plasma p-tau231 was significantly increased in amyloid-β PET quartiles 2-4, whereas CSF p-tau217 and plasma p-tau181 increased only at quartiles 3-4 and 4, respectively. +1 more finding

  20. 2021-02-13

    Genetic study of young-onset dementia using targeted gene panel sequencing in Taiwan

    ✓ Peer-reviewed Risk genes beyond APOE American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics

    Key finding: Plasma level of total tau was increased and Aβ42 and Aβ40 levels decreased in all groups of dementia patients compared to controls. +1 more finding

  21. 2021-02-13

    Plasma p-tau181, p-tau217, and other blood-based Alzheimer's disease biomarkers in a multi-ethnic, community study

    ✓ Peer-reviewed Getting a diagnosis Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Blood-based AD biomarker concentrations are associated with pathological and clinical diagnoses and can predict future development of clinical AD, providing evidence that they can be incorporated into multi-ethnic, community-based studies. +2 more findings

  22. 2021-02-12

    High levels of 27-hydroxycholesterol results in synaptic plasticity alterations in the hippocampus

    ✓ Peer-reviewed Disease mechanisms Scientific reports

    Key finding: Alterations in brain cholesterol homeostasis in midlife are correlated with a higher risk of developing Alzheimer's disease (AD). +4 more findings

  23. 2021-02-12

    Sleep in the Aging Brain

    ✓ Peer-reviewed Risk factors Brain sciences

    Key finding: However, maturational changes in sleep associated with aging do not easily appear as main factors, even though sleep alterations in the aging process lead to many detrimental consequences.

  24. 2021-02-12

    18F-AV-1451 positron emission tomography in neuropathological substrates of corticobasal syndrome

    ✓ Peer-reviewed Brain scans and imaging Brain : a journal of neurology

    Key finding: Subjects without amyloid, including three with pathologically confirmed corticobasal degeneration, showed greater regional 18F-AV-1451 retention and associated regional atrophy in areas commonly associated with corticobasal degeneration pathology than healthy control subjects [retention was higher compared to healthy controls (P = 0.0011), driven especially by the precentral gyrus (P = 0.011) and pallidum (P < 0.0001), and greater atrophy was seen in subjects compared to control subjects (P = 0.0004)]. +2 more findings

  25. 2021-02-12

    Mitovesicles are a novel population of extracellular vesicles of mitochondrial origin altered in Down syndrome

    ✓ Peer-reviewed Down syndrome and Alzheimer's Science advances

    Key finding: Mitochondrial dysfunction is an established hallmark of aging and neurodegenerative disorders such as Down syndrome (DS) and Alzheimer's disease (AD). +3 more findings

Browse the library by subject, with the full score breakdown →